Cargando…
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
The availability of a once-a-year zoledronic acid infusion heralds a new era in the management of osteoporosis. It virtually eliminates the problem of poor compliance with orally administered bisphosphonates and, because it bypasses the gastrointestinal tract, it is not associated with gastrointesti...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998805/ https://www.ncbi.nlm.nih.gov/pubmed/21151620 http://dx.doi.org/10.2147/DDDT.S6287 |